Trial Profile

Planned phase II programme of marizomib for solid tumours.

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 22 Apr 2008

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Marizomib (Primary) ; Vorinostat
Indications Solid tumours
Focus Therapeutic Use
Sponsors Nereus Pharmaceuticals; Triphase Accelerator Corporation

Most Recent Events

22 Apr 2008 New trial record.
19 Apr 2008 Nereus plans to initiate this trial in 2009, following successful completion of the phase Ib trial.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com